Skip to content

The Paired Donation Consortium Paired Donation Program

The Paired Donation Consortium Paired Donation Program

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00374400
Enrollment
100
Registered
2006-09-11
Start date
2004-09-30
Completion date
2007-11-30
Last updated
2008-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplant

Keywords

Kidney, Transplant, Paired donation, Living donor

Brief summary

The purpose of the protocol is to increase the number of living donor transplants by eliminating immune incompatibilities between donors and recipients through paired donation.

Detailed description

The purpose of the protocol is to increase the number of living donor transplants by eliminating immune incompatibilities between donors and recipients through paired donation. To increase the number of patients transplanted by paired donation by establishment of regional paired donation programs. To develop educational programs for potential living donors and their recipient, as well as the opportunity for transplant professionals to increase acceptance of the PDC to maximize the opportunity for organ donation. To identify and evaluate ethical and psychological factors that may influence the effects of paired donation on living kidney donation.

Interventions

None listed

Sponsors

The Paired Donation Consortium
CollaboratorOTHER
University of Cincinnati
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Persons capable of providing written informed consent. * Each recipient must have one or more medically suitable donors who are either ABO-incompatible or HLA-incompatible.

Exclusion criteria

* Persons with eligible, compatible donor.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026